Last edition
News about
Piramal Pharma Solutions, the CDMO arm of Piramal Pharma Ltd., has installed a state-of-the-art Korsch XM-12 bilayer tablet press at its Morpeth, UK facility to enhance precision, efficiency, and flexibility in oral solid manufacturing.
India Revokes Patent for Novartis Cardiac Drug Vymada, Opens Door for Generics
The Indian Patent Office (IPO) has revoked the patent for Novartis’ cardiac drug Vymada—known globally as Entresto—on the grounds of lack of novelty and inventive step.
Roche Pharma India Expands AIR Initiative to Boost Clinical Trial Capacity
Roche Pharma India has successfully completed the first phase of its Advanced Inclusive Research (AIR) Site Alliance programme. The initiative engaged 10 leading government hospitals across the country and trained nearly 400 professionals—including investigators, ethics committee members, and support staff—in global Good Clinical Practice standard.
FDA Grants BTD to Raludotatug Deruxtecan for Platinum-Resistant Ovarian Cancer
This is the first BTD granted for Raludotatug Deruxtecan, the second for the Daiichi Sankyo-Merck partnership and the 15th across Daiichi Sankyo’s oncology portfolio, marking a significant milestone in the companies’ joint efforts to develop innovative cancer therapies.
ASPA Elects New Governing Body, Names Ankit Gupta as President
The Authentication Solution Providers’ Association (ASPA) has elected a new governing body for the 2025–2027 term, with Ankit Gupta, Joint Managing Director of Holostik India, taking over as President.
Sagent Pharmaceuticals Enters Ophthalmic Market, Launches Travoprost Ophthalmic Solution
Travoprost is the first ophthalmic product offering in Sagent's portfolio, with plans to launch more products in the coming year.
REFCOLD India 2025 to Showcase Cold-Chain Innovations in Delhi
REFCOLD India 2025 will feature specialised platforms such as the innovation zone, demo zone, product launch pad, celebrating the next generation of engineers through a global student poster competition and outdoor displays, spotlighting next-generation technologies across multiple refrigeration applications.
BioAge Labs Initiates Phase 1 Trial of Novel NLRP3 Inhibitor BGE-102 for Obesity Treatment
BioAge Labs, a clinical-stage biotechnology company based in Emeryville, California, has announced the initiation of a Phase 1 clinical study of BGE-102, an orally available, brain-penetrant small molecule NLRP3 inhibitor being developed for the treatment of obesity.
Monte Rosa Therapeutics Partners with Novartis on Degraders for Immune Diseases
Monte Rosa to receive an upfront payment of USD 120 million, plus option maintenance payments, and is eligible for option exercise payments and development, regulatory and sales milestones, as well as tiered royalties on global net sales.
ANVISA Approves Concept Medical's MagicTouch SCB for CAD in Brazil
The approval enables commercial sales in Brazil, strengthening Concept Medical’s global footprint and advancing its mission to deliver safer and more effective treatment alternatives. The company is also undergoing ANVISA’s approval process for its wider DCB and DES portfolio, building on its robust clinical trial foundation.
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy